Sherif A. Gaballa, Taro Shimizu, Hidenori Ando, Haruka Takata, Sherif E. Emam, Eslam Ramadan, Youssef W. Naguib, Fatma M. Mady, Khaled A. Khaled & Tatsuhiro Ishida. (2023) Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives. Journal of Pharmaceutical Sciences.
Crossref
Gholamreza Karimi, Sina Fatemi, Bahram Memar, Mohammad-Bagher Khorrami, Arian Amali, Mahmood Sadeghi, Seyed-Alireza Esmaeili & Bamdad Riahi-Zanjani. (2023) Melittin as a safe compound to BALB/c mice immune system; a tiered approach immunotoxicity screening. BMC Complementary Medicine and Therapies 23:1.
Crossref
Nur Aqlili Riana Alias, Winfrey Pui Yee Hoo, Pui Yan Siak, Siti Sarah Othman, Noorjahan Banu Mohammed Alitheen, Lionel Lian Aun In, Raha Abdul Rahim & Adelene Ai-Lian Song. (2023) Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer. International Journal of Molecular Sciences 24:10, pages 8928.
Crossref
Amjad Islam Aqib, Khazeena Atta, Afshan Muneer, Muhammad Luqman Sohail, Kashif Rahim & Firasat Hussain. 2023. Application of Natural Products in SARS-CoV-2. Application of Natural Products in SARS-CoV-2
491
507
.
Anqi Wang, Yuan Zheng, Wanxin Zhu, Liuxin Yang, Yang Yang & Jinliang Peng. (2022) Melittin-Based Nano-Delivery Systems for Cancer Therapy. Biomolecules 12:1, pages 118.
Crossref
Hamed Memariani & Mojtaba Memariani. (2021) Melittin as a promising anti-protozoan peptide: current knowledge and future prospects. AMB Express 11:1.
Crossref
Shantanu Guha, Ryan P. Ferrie, Jenisha Ghimire, Cristina R. Ventura, Eric Wu, Leisheng Sun, Sarah Y. Kim, Gregory R. Wiedman, Kalina Hristova & Wimley C. Wimley. (2021) Applications and evolution of melittin, the quintessential membrane active peptide. Biochemical Pharmacology 193, pages 114769.
Crossref
Elham Jafari & Shirin Mahmoodi. (2021) Design, expression, and purification of a multi-epitope vaccine against Helicobacter Pylori based on Melittin as an adjuvant. Microbial Pathogenesis 157, pages 104970.
Crossref
Meilyn Sylvestre, Shixian Lv, Lucy F. Yang, Nicholas Luera, David J. Peeler, Bing-Mae Chen, Steve R. Roffler & Suzie H. Pun. (2021) Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice. Journal of Controlled Release 331, pages 142-153.
Crossref
Steven Willows & Marianna Kulka. (2020) Harnessing the Power of Mast Cells in unconventional Immunotherapy Strategies and Vaccine Adjuvants. Cells 9:12, pages 2713.
Crossref
Keneth Iceland Kasozi, Gniewko Niedbała, Mohammed Alqarni, Gerald Zirintunda, Fred Ssempijja, Simon Peter Musinguzi, Ibe Michael Usman, Kevin Matama, Helal F. Hetta, Ngala Elvis Mbiydzenyuy, Gaber El-Saber Batiha, Amany Magdy Beshbishy & Susan Christina Welburn. (2020) Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections. Frontiers in Public Health 8.
Crossref
Konstantinos Katsoulis-Dimitriou, Johanna Kotrba, Martin Voss, Jan Dudeck & Anne Dudeck. (2020) Mast Cell Functions Linking Innate Sensing to Adaptive Immunity. Cells 9:12, pages 2538.
Crossref
Jinxia Qi, Yonghui Chen, Tiantian Xue, Yue Lin, Shiyuan Huang, Shuyan Cao, Xiaona Wang, Yu Su & Zhenkun Lin. (2020) Graphene oxide-based magnetic nanocomposites for the delivery of melittin to cervical cancer HeLa cells. Nanotechnology 31:6, pages 065102.
Crossref
Brandi T. Johnson-Weaver, Soman N. Abraham & Herman F. Staats. 2020. Mucosal Vaccines. Mucosal Vaccines
167
183
.
Hamed Memariani, Mojtaba Memariani, Hamideh Moravvej & Mohammad Shahidi-Dadras. (2019) Melittin: a venom-derived peptide with promising anti-viral properties. European Journal of Clinical Microbiology & Infectious Diseases 39:1, pages 5-17.
Crossref
Hannaneh Zarrinnahad, Amir Mahmoodzadeh, Monireh Parviz Hamidi, Mehdi Mahdavi, Ali Moradi, Kamran Pooshang Bagheri & Delavar Shahbazzadeh. (2017) Apoptotic Effect of Melittin Purified from Iranian Honey Bee Venom on Human Cervical Cancer HeLa Cell Line. International Journal of Peptide Research and Therapeutics 24:4, pages 563-570.
Crossref
Abdulmalik Alqarni, Valerie Ferro, John Parkinson, Mark Dufton & David Watson. (2018) Effect of Melittin on Metabolomic Profile and Cytokine Production in PMA-Differentiated THP-1 Cells. Vaccines 6:4, pages 72.
Crossref
Brandi Johnson-Weaver, Hae Woong Choi, Soman N Abraham & Herman F Staats. (2018) Mast cell activators as novel immune regulators. Current Opinion in Pharmacology 41, pages 89-95.
Crossref
Evelyn Sun, Corrie R. Belanger, Evan F. Haney & Robert E.W. Hancock. 2018. Peptide Applications in Biomedicine, Biotechnology and Bioengineering. Peptide Applications in Biomedicine, Biotechnology and Bioengineering
253
285
.
N. Woods, K. Niwasabutra, R. Acevedo, J. Igoli, N.A. Altwaijry, J. Tusiimire, A.I. Gray, D.G. Watson & V.A. Ferro. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
211
229
.
Jonans Tusiimire, Jennifer Wallace, Nicola Woods, Mark Dufton, John Parkinson, Grainne Abbott, Carol Clements, Louise Young, Jin Park, Jong Jeon, Valerie Ferro & David Watson. (2016) Effect of Bee Venom and Its Fractions on the Release of Pro-Inflammatory Cytokines in PMA-Differentiated U937 Cells Co-Stimulated with LPS. Vaccines 4:2, pages 11.
Crossref
Kim Alan Brogden, Amber M. Bates & Carol L. Fischer. 2016. Antimicrobial Peptides. Antimicrobial Peptides
129
146
.
Karl G KohlgrafLindsey C PingelDeborah E DietrichKim A Brogden. (2010) Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiology 5:1, pages 99-113.
Crossref
Maryam Amidi, Hubert C. Pellikaan, Hoang Hirschberg, Anne H. de Boer, Daan J.A. Crommelin, Wim E. Hennink, Gideon Kersten & Wim Jiskoot. (2007) Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: Preparation, characterization and evaluation in guinea pigs. Vaccine 25:37-38, pages 6818-6829.
Crossref
Lindsey C. Pingel, Xiaoying Lu & Kim A. Brogden. 2007. Virulence Mechanisms of Bacterial Pathogens. Virulence Mechanisms of Bacterial Pathogens
281
295
.